Back
C4 Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
20
CCCC
C4 Therapeutics
Last Price:
5.51
Seasonality Move:
60.44%
Sell
40
NBY
NovaBay Pharmaceuticals
Last Price:
0.80
Seasonality Move:
-7.72%
Sell
20
C4 Therapeutics (CCCC)
is a Sell
Is C4 Therapeutics a Buy, Sell or Hold?
- The current C4 Therapeutics [CCCC] share price is $5.89. The Score for CCCC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- CCCC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CCCC Stock Price Chart
What is C4 Therapeutics's stock price today?
-
The C4 Therapeutics share price today is $5.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CCCC is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
CCCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 49.02 | Sell |
| Chaikin Money Flow: | -338413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.42 - 6.32) | Buy |
| Bollinger Bands (100): | (5.19 - 6.51) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 55.22 | Buy |
| Chaikin Money Flow: | 6757 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 0.72) | Buy |
| Bollinger Bands (100): | (0.29 - 1.67) | Sell |
CCCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.93 | Sell |
| 20-day SMA: | 6.04 | Sell |
| 50-day SMA: | 5.95 | Sell |
| 200-day SMA: | 6.47 | Sell |
| 8-day EMA: | 5.96 | Sell |
| 20-day EMA: | 5.94 | Sell |
| 50-day EMA: | 5.94 | Sell |
| 200-day EMA: | 5.86 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.72 | Sell |
| 20-day SMA: | 0.66 | Buy |
| 50-day SMA: | 0.62 | Buy |
| 200-day SMA: | 2.54 | Sell |
| 8-day EMA: | 0.7 | Buy |
| 20-day EMA: | 0.68 | Buy |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 6.02 | Sell |
C4 Therapeutics Earnings Growth & CCCC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $0.35 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
C4 Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||